Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers
- 1 June 2003
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 39 (9) , 1242-1250
- https://doi.org/10.1016/s0959-8049(03)00232-6
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: a combined analysis of 881 casesCarcinogenesis: Integrative Cancer Research, 1999
- A novel molecular staging protocol for non-small cell lung cancerOncogene, 1999
- Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationEuropean Journal Of Cancer, 1996
- Comparative analysis of p53 gene mutations and protein accumulation in human non‐small‐cell lung cancerInternational Journal of Cancer, 1995
- Studies on Clinicopathological Features of Lung Cancer Patients with K-ras/p53 Gene Alterations: Comparison between Younger and Older GroupsOncology, 1995
- p53 in Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1994
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958